Lola Koktysh[email protected]MRIQuantitative imaging biomarkers show promise for NASHQuantitative imaging biomarkers are a promising approach for evaluating normal biological or pathogenic processes, as well as response to treatment and intervention. One near-term clinical application is the assessment of nonalcoholic steatohepatitis (NASH), according to Lola Koktysh of ScienceSoft.March 6, 2017Page 1 of 1Top StoriesRSNA 2025GLP-1 drugs reduce heart plaque progression in diabetes patientsStudy findings could be good news for people with diabetes, as they tend to be at higher risk of cardiovascular disease.RSNA 2025Imaging can help 'All of Us'RSNA 2025GE HealthCare features new MRI scanners, PCCT systemRSNA 2025Abdominal obesity linked to heart damageRSNA 2025Breast cancer incidence rising in younger women